China’s Fosun inks US$1.3 billion deal for Indian pharma company

Shanghai-based conglomerate Fosun said on Thursday it has inked a US$1.3 billion deal to buy the controlling interest in an Indian pharmaceutical company held by private equity fund KKR and the company’s founders.

Lees hier het hele artikel